Epidemiology, clinical features and management of infections due to community methicillin-resistant Staphylococcus aureus (cMRSA)

Internal Medicine Journal

Volumn 35, Issue SUPPL. 2, 2005, Pages

  Gosbell, I B ^a,b  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Antibiotic susceptibility; Community acquired infections; Epidemiology; Methicillin resistance; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC RESISTANCE; AUSTRALIA; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DNA FINGERPRINTING; EPIDEMIC; FURUNCULOSIS; GENE TRANSFER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TOXIC SHOCK SYNDROME; COMMUNICABLE DISEASE; DRUG EFFECT; GENETICS; HUMAN; PATHOGENICITY; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VIRULENCE;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; AUSTRALIA; COMMUNITY-ACQUIRED INFECTIONS; DNA FINGERPRINTING; HUMANS; METHICILLIN RESISTANCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 33645832001     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1444-0903.2005.00985.x     Document Type: Review

References (153)

1. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001; 7: 178-82.
2. Saravolatz LD, Markowitz N, Arking L, Pohlod D, Fisher E. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med 1982; 96: 11-16.
3. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279: 593-8.
4. Pate KR, Nolan RL, Bannerman TL, Feldman S. Methicillin-resistant Staphylococcus aureus in the community. Lancet 1995; 346: 978.
5. Taylor G, Kirkland T, Kowalewska-Grochowska K, Wang Y. A multistrain cluster of methicillin-resistant Staphylococcus aureus based in a native community. Can J Infect Dis 1990; 1: 121-6.
6. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993; 25: 97-108.
7. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Aust 1996; 164: 721-3.
8. Heffernan H, Davies H, Brett M. Current epidemiology of MRSA in New Zealand. LabLink 1997; 4: 25-6.
9. Brian MJ, Michael A. Community-acquired infection with methicillin-resistant Staphylococcus aureus in Papua New Guinea. Pediatr Infect Dis J 1989; 8: 807-8.
10. Durmaz B, Durmaz R, Sahin K. Methicillin-resistance among Turkish isolates of Staphylococcus aureus strains from nosocomial and community infections and their resistance patterns using various antimicrobial agents. J Hosp Infect 1997; 37: 325-9.
11. Collignon P, Gosbell I, Vickery A, Nimmo G, Stylianopoulos T, Gottlieb T. Community-acquired meticillin-resistant Staphylococcus aureus in Australia. Australian Group on Antimicrobial Resistance. Lancet 1998; 352: 145-6.
12. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O'Brien FG et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40: 4289-94.
13. Nimmo GR. Community MRSA Strains: Where Are They? Western Pacific Congress of Chemotherapy and Infectious Diseases; 2002 December 1-5; Perth, Australia; 2003.
14. Gosbell IB, Mercer JL, Neville SA, Crone SA, Chant KG, Jalaludin BB et al. Non-multiresistant and multiresistant methicillin-resistant Staphylococcus aureus in community-acquired infections. Med J Aust 2001; 174: 627-30.
15. Hunt C, Dionne M, Delorme M, Murdock D, Erdrich A, Wolsey D et al. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 1999; 48: 707-10.
16. Riley TV, Carson CF, Bowman RA, Mulgrave L, Golledge CL, Pearman JW et al. Mupirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust 1994; 161: 397-8.
17. Munckhof WJ, Harper J, Schooneveldt J, Nimmo GR. Recent appearance of clindamycin resistance in community-acquired methicillin-resistant Staphylococcus aureus (MRSA) in southeast Queensland. Med J Aust 2002; 176: 243-4.
18. Barbagiannakos T, Gosbell IB, Mercer JL, Vickery AM, Watson M, Warren S et al. Molecular Epidemiology of Non-multiresistant MRSA from a Paediatric Teaching Hospital in Sydney, Australia. International Symposium on Staphylococci and Staphylococcal Infections; 2004 October 24-27; Charleston, SC, USA; 2004.
19. Cookson BD. Methicillin-resistant Staphylococcus aureus in the community: new battlefronts, or are the battles lost? Infect Control Hosp Epidemiol 2000; 21: 398-403.
20. Gosbell IB, Mercer JL, Neville SA, Chant KG, Munro R. Community-acquired, non-multiresistant oxacillin-resistant Staphylococcus aureus ('NORSA') in south western Sydney. Pathology 2001; 33: 206-10.
21. Lin JC, Yeh KM, Peng MY, Chang FY. Community-acquired methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: risk factors for acquisition, clinical features and outcome. J Microbiol Immunol Infect 2004; 37: 24-8.
22. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36: 131-9.
23. Tacconelli E, Venkataraman L, De Girolami PCD, Agata EM. Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare- associated strains. J Antimicrob Chemother 2004; 53: 474-9.
24. Tambyah PA, Habib AG, Ng TM, Goh H, Kumarasinghe G. Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually 'healthcare associated'. Infect Control Hosp Epidemiol 2003; 24: 436-8.
25. Murchan S, Kaufmann ME, Deplano A, de Ryck R, Struelens M, Zinn CE et al. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol 2003; 41: 1574-85.
26. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002; 99: 7687-92.
27. Centers for Disease Control and Prevention. Community-associated methicillin-resistant Staphylococcus aureus infections in Pacific Islanders - Hawaii, 2001-2003. MMWR Morb Mortal Wkly Rep 2004; 53: 767-70.
28. McDonald P, Carnie J, Christ V, Collignon P, Kampen R, Masters C et al. Appendix 1. Consensus numerator definitions. In: Infection Control Guidelines for the Prevention of Transmission of Infectious Diseases in the Health Care Setting. Canberra: Department of Health and Ageing, Commonwealth of Australia; 2004: A1-9.
29. Auricht E, Borgert J, Butler M, Cadwallader H, Collignon P, Eades N et al. Uniform national numerator definitions for infection control clinical indicators: surgical site infection and health-care related bloodstream infection. Aust Infect Cont 1999; 4: 12-14.
30. Saravolatz LD, Pohlod DJ, Arking LM. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann Intern Med 1982; 97: 325-9.
31. Riley TV, Pearman JW, Rouse IL. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust 1995; 163: 412-14.
32. Riley TV, Rouse IL. Methicillin-resistant Staphylococcus aureus in Western Australia, 1983-1992. J Hosp Infect 1995; 29: 177-88.
33. Pearman JW. MRSA: the pathogen hospitals dread. Microbiol Aust 1996; 17: 29-31.
34. Torvaldsen S, Roberts C, Riley TV. The continuing evolution of methicillin-resistant Staphylococcus aureus in Western Australia. Infect Control Hosp Epidemiol 1999; 20: 133-5.
35. Coombs G. Workshop - MRSA Typing: Applications of Methods in an MRSA Typing Laboratory. Antimicrobials 2003. Melbourne, Australia: Australian Society for Antimicrobials 4th Annual Scientific Meeting. 2003 May 1-5; 2003.
36. O'Brien FG, Lim TT, Chong FN, Coombs GW, Enright MC, Robinson DA et al. Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol 2004; 42: 3185-90.
37. Coombs GW, Nimmo GR, Bell JM, Huygens F, O'Brien FG, Malkowski MJ et al. Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J Clin Microbiol 2004; 42: 4735-43.
38. Heffernan H, Davies H, Brett M. MRSA increasing in New Zealand. NZ Public Health Rep 1995; 2: 97-9.
39. Nimmo GR, Schooneveldt J, O'Kane G, McCall B, Vickery A. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeastern Queensland, Australia. J Clin Microbiol 2000; 38: 3926-31.
40. Gosbell IB. Emergence of community-acquired, oxacillin-resistant Staphylococcus aureus in south western Sydney. Thesis [Doctor of Medicine]; University of New South Wales, Sydney; 2003. Available from: http://www.library.unsw.edu.au/~thesis/adt-NUN/public/adt-NUN20030801.121441/ index.html
41. Moreno F, Crisp C, Jorgensen JH, Patterson JE. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995; 21: 1308-12.
42. Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR. Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland. Aust Int J Infect Dis 2003; 7: 259-64.
43. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9: 978-84.
44. Gosbell IB, Barbagiannakos T, Burke H, Kennedy C, Vickery A, Lambie P et al. Community MRSA in Far Western New South Wales, Australia: Emergence of Two Epidemic Clones and Emergence of Panton-Valentine Leukocidin in a Previous Naive Clone. International Symposium on Staphylococci and Staphylococcal Infections; 2004 October 24-27; Charleston, SC, USA; 2004.
45. Hussain FM, Boyle-Vavra S, Bethel CD, Daum RS. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Infect Dis J 2000; 19: 1163-6.
46. Culpepper R, Nolan R, Chapman S, Kennedy A, Currier M. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison - Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001; 50: 919-22.
47. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999; 29: 797-800.
48. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. J Hosp Infect 1998; 38: 273-81.
49. Johnston BL. Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia - a critical review. Semin Respir Infect 1994; 9: 199-206.
50. Akram J, Glatt AE. True community-acquired methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998; 19: 106-7.
51. Collins N, Gosbell IB, Wilson S. Community-acquired MRSA bacteraemia. Med J Aust 2002; 177: 55-6.
52. Murray RJ, Lim TT, Pearson JC, Grubb WB, Lum GD. Community-onset methicillin-resistant Staphylococcus aureus bacteremia in Northern Australia. Int J Infect Dis 2004; 8: 275-83.
53. Nimmo GR, Playford EG. Community-acquired MRSA bacteraemia: four additional cases including one associated with severe pneumonia. Med J Aust 2003; 178: 245.
54. Peleg AY, Munckhof WJ. Fatal necrotising pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus (MRSA). Med J Aust 2004; 181: 228-9.
55. Waldvogel FA, Mandell GL, Bennett JE, Dolin R. Staphylococcus aureus (including staphylococcal toxic shock syndrome). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone; 2000: 2069-92.
56. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002; 359: 1819-27.
57. van de Velde H. Étude sur le mécanisme de la virulence du Staphylocoque pyogène. Cellule 1894; 10: 401-60.
58. Panton PN, Valentine FCO. Staphylococcal toxin. Lancet 1932; 1: 506-8.
59. Bohach GA, Dinges MM, Mitchell DT, Ohlendorf DH, Schlievert PM. Exotoxins. In: Crossley KB, Archer GL, eds. The Staphylococci in Human Disease, 1st edn. New York: Churchill Livingstone; 1997: 83-111.
60. Kaneko J, Kimura T, Kawakami Y, Tomita T, Kamio Y. Panton-Valentine leukocidin genes in a phage-like particle isolated from mitomycin C-treated Staphylococcus aureus V8 (ATCC 49775). Biosci Biotech Biochem 1997; 61: 1960-2.
61. Ward PD, Turner WH. Identification of staphylococcal Panton-Valentine leukocidin as a potent dermonecrotic toxin. Infect Immun 1980; 28: 393-7.
62. Cribier B, Prevost G, Couppie P, Finck-Barbancon V, Grosshans E, Piemont Y. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology 1992; 185: 175-80.
63. Prevost G, Couppie P, Prevost P, Gayet S, Petiau P, Cribier B et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 1995; 42: 237-45.
64. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29: 1128-32.
65. Gillet Y, Issartel B, Vanhems P, Lina G, Vandenesch F, Etienne J et al. [Severe staphylococcal pneumonia in children]. Arch Pediatr 2001; 8 Suppl 4: 742S-746S.
66. de Bentzmann S, Tristan A, Etienne J, Brousse N, Vandenesch F, Lina G. Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type I and IV collagens and laminin. J Infect Dis 2004; 190: 1506-15.
67. Robinson DA, Enright MC. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47: 3926-34.
68. Yamaguchi T, Yokota J, Terajima J, Hayashi M, Aepfelbacher M, Ohara M et al. Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J Infect Dis 2002; 185: 1511-16.
69. Liassine N, Auckenthaler R, Descombes MC, Bes M, Vandenesch F, Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J Clin Microbiol 2004; 42: 825-8.
70. van der Mee-Marquet N, Lina G, Quentin R, Yaouanc-Lapalle H, Fievre C, Takahashi N et al. Staphylococcal exanthematous disease in a newborn due to a virulent methicillin-resistant Staphylococcus aureus strain containing the TSST-1 gene in Europe: an alert for neonatologists. J Clin Microbiol 2003; 41: 4883-4.
71. Adhikari RP, Cook GM, Lamont I, Lang S, Heffernan H, Smith JM. Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2002; 50: 825-31.
72. Charlebois ED, Perdreau-Remington F, Kreiswirth B, Bangsberg DR, Ciccarone D, Diep BA et al. Origins of community strains of methicillin- resistant Staphylococcus aureus. Clin Infect Dis 2004; 39: 47-54.
73. Charlebois ED, Bangsberg DR, Moss NJ, Moore MR, Moss AR, Chambers HF et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002; 34: 425-33.
74. Young DM, Harris HW, Charlebois ED, Chambers H, Campbell A, Perdreau-Remington F et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg 2004; 139: 947-51; discussion 51-3.
75. Peleg A, Munckhof WJ, Kleinschmidt SL, Stephens A, Huygens F, Giffard PM. Life Threatening Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA): A Highly Virulent Pathogen. Australasian Society for Infectious Diseases Inc, Annual Scientific Meeting, 2004, Abstract 1215.
76. Groom AV, Wolsey DH, Naimi TS, Smith K, Johnson S, Boxrud D et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001; 286: 1201-5.
77. Baggett HC, Hennessy TW, Leman R, Hamlin C, Bruden D, Reasonover A et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol 2003; 24: 397-402.
78. Baggett HC, Hennessy TW, Rudolph K, Bruden D, Reasonover A, Parkinson A et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004; 189: 1565-73.
79. Embil J, Ramotar K, Romance L, Alfa M, Conly J, Cronk S et al. Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect Control Hosp Epidemiol 1994; 15: 646-51.
80. Stacey AR, Endersby KE, Chan PC, Marples RR. An outbreak of methicillin resistant Staphylococcus aureus infection in a rugby football team. Br J Sports Med 1998; 32: 153-4.
81. Lindenmayer JM, Schoenfeld S, O'Grady R, Carney JK. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med 1998; 158: 895-9.
82. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants - Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 2003; 52: 793-5.
83. Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, Garfinkel B et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005; 352: 468-75.
84. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections in correctional facilities - Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 2003; 52: 992-6.
85. Diep BA, Sensabaugh GF, Somboona NS, Carleton HA, Perdreau-Remington F. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 2004; 42: 2080-4.
86. Baum SE, Morris JT, Dooley DP, Watson R. Methicillin-resistant Staphylococcus aureus in an adult military beneficiary population lacking risk factors: susceptibility to orally available agents. Mil Med 2003; 168: 126-30.
87. Campbell KM, Vaughn AF, Russell KL, Smith B, Jimenez DL, Barrozo CP et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol 2004; 42: 4050-3.
88. Garthwaite TL, Fielding JE. Fact Sheet for Health Care Providers: Community-Onset MRSA Among HIV-Positive MSM. Available from: http://www.lapublichealth.org/std/MRSAproviders.pdf (accessed March 31, 2005).
89. Anonymous. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections - Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2003; 52: 88.
90. Shahin R, Johnson IL, Jamieson F, McGeer A, Tolkin J, Ford-Jones EL. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Toronto Child Care Center Study Group. Arch Pediatr Adolesc Med 1999; 153: 864-8.
91. Adcock PM, Pastor P, Medley F, Patterson JE, Murphy TV. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 1998; 178: 577-80.
92. Huang YC, Su LH, Lin TY. Nasal carriage of methicillin-resistant Staphylococcus aureus in contacts of an adolescent with community-acquired disseminated disease. Pediatr Infect Dis J 2004; 23: 919-22.
93. Borer A, Gilad J, Yagupsky P, Peled N, Porat N, Trefler R et al. Community-acquired methicillin-resistant Staphylococcus aureus in institutionalized adults with developmental disabilities. Emerg Infect Dis 2002; 8: 966-70.
94. Landen MG, McCumber BJ, Asay ED, Egeland GM. Outbreak of boils in an Alaskan village: a case control study. West J Med 2000; 172: 235-9.
95. Lang S, Taylor S, Morris A. Community-acquired methicillin-resistant Staphylococcus aureus. Antibiot Chemother 2001; 5: 12-13.
96. Leman R, Alvarado-Ramy F, Pocock S, Barg N, Kellum M, McAllister S et al. Nasal carriage of methicillin-resistant Staphylococcus aureus in an American Indian population. Infect Control Hosp Epidemiol 2004; 25: 121-5.
97. Kenner J, O'Connor T, Piantanida N, Fishbain J, Eberly B, Viscount H et al. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 2003; 24: 439-44.
98. Hussain FM, Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatr Infect Dis J 2001; 20: 763-7.
99. Bischoff WE, Wallis ML, Tucker KB, Reboussin BA, Sherertz RJ. Staphylococcus aureus nasal carriage in a student community: prevalence, clonal relationships, and risk factors. Infect Control Hosp Epidemiol 2004; 25: 485-91.
100. Upton A, Lang S, Heffernan H. Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother 2003; 51: 613-7.
101. Mason BW, Howard AJ. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study. Int J Antimicrob Agents 2004; 23: 300-3.
102. Mason BW, Howard AJ, Magee JT. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing. J Antimicrob Chemother 2003; 51: 1033-6.
103. Witte W, Cuny C, Strommenger B, Braulke C, Heuck D. Emergence of a new community acquired MRSA strain in Germany. Euro Surveill 2004; 9: 1-2.
104. Gosbell IB, Barbagiannakos T, Mercer JL. South Western Area Pathology Service Staphylococcal Reference Facility Quarterly Report 4, First Annual Report Period: 8/10/02-30/9/03. South Western Area Pathology Service; 2003. Report No. 1.
105. Blair JE, Williams REO. Phage typing of staphylococci. Bull WHO 1961; 24: 771-8.
106. Richardson JF, Reith S. Characterization of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods. J Hosp Infect 1993; 25: 45-52.
107. Hanssen AM, Kjeldsen G, Sollid JU. Local variants of staphylococcal cassette chromosome mec in sporadic methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci: evidence of horizontal gene transfer? Antimicrob Agents Chemother 2004; 48: 285-96.
108. Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001; 9: 486-93.
109. Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004; 48: 2637-51.
110. Gosbell IB. Symposium 2 - AGAR Staphylococcus Awareness Program: Community MRSA. Antimicrobials 2003, Australian Society for Antimicrobials 4th Annual Scientific Meeting; 2003 May 1-5; Melbourne, Australia; 2003.
111. Martin BT, Palasanthiran P, Gosbell IB, Barbagiannakos T, Best EJ, Henry RL. Severe childhood pneumonitis caused by the Queensland strain of commuity-acquired methicillin-resistant Staphylococcus aureus. Med J Aust 2005; 182: 249.
112. Coombs G. Symposia G. NORSA and MORSA in the Community. Epidemiology - the AGAR Data. Antimicrobials 2002, Australian Society for Antimicrobials 3rd Annual Scientific Meeting; 2002 February 28-March 2; Sydney, Australia; 2002.
113. Austin DJ, Anderson RM. Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales. J Infect Dis 1999; 179: 883-91.
114. Johnson AP, Aucken HM, Cavendish S, Ganner M, Wale MC, Warner M et al. Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). J Antimicrob Chemother 2001; 48: 143-4.
115. Pearman JW, Coombs GW, Grubb WB, O'Brien F. A British epidemic strain of methicillin-resistant Staphylococcus aureus (UK EMRSA-15) in Western Australia. Med J Aust 2001; 174: 662.
116. O'Brien FG, Pearman JW, Gracey M, Riley TV, Grubb WB. Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. J Clin Microbiol 1999; 37: 2858-62.
117. Townsend DE, Ashdown N, Bolton S, Bradley J, Duckworth G, Moorhouse EC et al. The international spread of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1987; 9: 60-71.
118. Gosbell IB, Neville SA, Mercer JL, Fernandes LA, Fernandes CJ. Detection of intrinsic oxacillin resistance in non-multiresistant, oxacillin-resistant Staphylococcus aureus (NORSA). J Antimicrob Chemother 2003; 51: 468-70.
119. Merlino J, Watson J, Rose B, Beard-Pegler M, Gottlieb T, Bradbury R et al. Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and non-multidrug-resistant Staphylococcus aureus in central Sydney, Australia. J Antimicrob Chemother 2002; 49: 793-801.
120. Skov R, Smyth R, Clausen M, Larsen AR, Frimodt-Møller N, Olsson-Liljequist B et al. Evaluation of a cefoxitin 30 μg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2003; 52: 204-7.
121. Fernandes C, Fernandes L, Collignon P. Cefoxitin resistance as a surrogate marker for the detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2005; 55: 506-10.
122. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 14th Informational Supplement. In: NCCLS Doucument M100-S14. Wayne, PA: NCCLS; 2004.
123. Berger-Bachi B, Crossley KB, Archer GL. Resistance to β-lactam antibiotics. Resistance not medicated by β-lactamase (methicillin resistance). In: Crossley KB, Archer GL, eds. The Staphylococci in Human Disease. New York: Churchill Livingstone; 1997: 158-74.
124. Brakstad OG, Tveten Y, Nato F, Fournier JM. Comparison of various methods and reagents for species identification of Staphylococcus aureus positive or negative for the mecA gene. APMIS 1993; 101: 651-4.
125. Richard P, Meyran M, Carpentier E, Thabaut A, Drugeon HB. Comparison of phenotypic methods and DNA hybridization for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1994; 32: 613-17.
126. van Leeuwen WB, van Pelt C, Luijendijk A, Verbrugh HA, Goessens WH. Rapid detection of methicillin resistance in Staphylococcus aureus isolates by the MRSA-screen latex agglutination test. J Clin Microbiol 1999; 37: 3029-30.
127. Mariott DJE, Kearney P. Further evaluation of the MRSA-Screen Kit for rapid detection of methicillin resistance. J Clin Microbiol 1999; 37: 3783-4.
128. Gosbell IB, Neville SA, Mercer JL, Fernandes LA, Fernandes CJ. Evaluation of the MRSA-Screen Test in detecting oxacillin resistance in community and hospital isolates of Staphylococcus aureus. Pathology 2001; 33: 492-4.
129. Swenson JM, Williams PP, Killgore G, O'Hara CM, Tenover FC. Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms. J Clin Microbiol 2001; 39: 3785-8.
130. O'Brien FG, Botterill CI, Endersby TG, Lim RL, Grubb WB, Gustafson JE. Heterogeneous expression of fusidic acid resistance in Staphylococcus aureus with plasmid or chromosomally encoded fusidic acid resistance genes. Pathology 1998; 30: 299-303.
131. Gosbell IB. Methicillin-resistant Staphylococcus aureus. Impact on dermatology practice. Am J Clin Dermatol 2004; 5: 239-59.
132. Collignon P. Symposium 6. Community Methicillin Resistant Staphylococcus aureus (cMRSA): An Emerging Problem Worldwide. Leura, NSW, Australia: Australasian Society for Infectious Diseases Inc, Annual Scientific Meeting, 2000; 2000.
133. Neu HC. Bacterial resistance to fluoroquinolones. Rev Infect Dis 1988; 10 Suppl 1: S57-63.
134. Nightingale CH, Mattoes HM, Nightingale CH, Murakawa T, Ambrose PG. Macrolide, azalide, and ketolide pharmacodynamics. In: Nightingale CH, Murakawa T, Ambrose PG, eds. Antimicrobial Pharmacodynamics in Theory and Clinical Practice. New York: Marcel Dekker; 2002: 205-20.
135. Cunha BA, Mattoes HM, Nightingale CH, Murakawa T, Ambrose PG. Tetracycline pharmacodynamics. In: Nightingale CH, Murakawa T, Ambrose PG, eds. Antimicrobial Pharmacodynamics in Theory and Clinical Practice. New York: Marcel Dekker; 2002: 247-57.
136. Nichols RL, Graham DR, Barriere SL, Rodgers A, Wilson SE, Zervos M et al. Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Group. J Antimicrob Chemother 1999; 44: 263-73.
137. Griswold MW, Lomaestro BM, Briceland LL. Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination. Am J Health Syst Pharm 1996; 53: 2045-53.
138. Etienne J. MRSA Communautaires (Entre Autre). Available from: http://www.md.ucl.ac.be/seminfect/Etienne-24-02-05/Etienne-24-02-05.pdf (accessed April 22, 2005).
139. Kernodle DS, Kaiser AB. Wound infections and surgical prophylaxis. In: Crossley KB, Archer GL, eds. The Staphylococci in Human Disease. New York: Churchill Livingstone; 1997: 355-77.
140. Gauduchon V, Cozon G, Vandenesch F, Genestier AL, Eyssade N, Peyrol S et al. Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 2004; 189: 346-53.
141. Takei S, Arora YK, Walker SM. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993; 91: 602-7.
142. Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 1999; 28: 800-7.
143. Saiman L, O'Keefe M, Graham PL III, Wu F, Said-Salim B, Kreiswirth B et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003; 37: 1313-19.
144. Le Coq M, Simon I, Sire C, Tissot-Guerraz F, Fournier L, Aho S et al. Épidémie d'infections nosocomiales à Staphylococcus aureus résistant à la méticilline dans une maternité. Pathol Biol (Paris) 2001; 49: 16-22.
145. Urth T, Skov R, Schonheyder HC. Spread of a methicillin-resistant Staphylococcus aureus ST80-IV clone in a Danish community. Infect Control Hosp Epidemiol 2005; 26: 144-9.
146. Shimada M, Kamakura T, Itasaka H, Matsumata T, Hashizume MSK. The significance of methicillin-resistant Staphylococcus aureus infection in general surgery: a multivariate analysis of risk factors and preventive approaches. Surg Today 1993; 23: 880-4.
147. Coll PP, Crabtree BF, O'Connor PJ, Klenzak S. Clinical risk factors for methicillin-resistant Staphylococcus aureus bacteriuria in a skilled-care nursing home. Arch Fam Med 1994; 3: 357-60.
148. Pujol M, Pena C, Pallares R, Ayats J, Ariza J, Gudiol F. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994; 13: 96-102.
149. Doebbeling BN. The epidemiology of methicillin-resistant Staphylococcus aureus colonisation and infection. J Chemother 1995; 7 Suppl 3: 99-103.
150. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982; 97: 309-17.
151. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national
152. Anonymous. Epidemic methicillin resistant Staphylococcus aureus in 1993. CDR Wkly 1994; 4: 17.
153. Kerr S, Kerr GE, Mackintosh CA, Marples RR. A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales. J Hosp Infect 1990; 16: 35-48.